矛盾的变化:EMMPRIN组织和血水平在与马凡综合征相关的胸前大动脉动脉瘤中

相关实验视频

Updated: May 5, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair

A New Murine Model of Endovascular Aortic Aneurysm Repair

Published on: July 7, 2013

Kyle C Alexander¹, Carlton W Anderson², Chris B Agala¹

¹Department of Surgery, Division of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Journal of clinical medicine

|March 28, 2024

概括

在马凡综合征 (MFS) 胸前动脉动脉瘤 (TAA) 中,细胞外矩阵金属蛋白酶诱导剂 (EMMPRIN) 的水平在组织和血之间有所不同. MT1-MMP影响EMMPRIN分泌,这表明MFSTAA的诊断潜力.

科学领域:

心血管生物学心血管生物学
细胞外矩阵动力学
遗传连接组织疾病遗传连接组织疾病

背景情况:

与马凡综合征 (MFS) 相关的胸前大动脉动脉瘤 (TAA) 呈现出独特的细胞外矩阵金属蛋白酶诱导体 (EMMPRIN) 配置文件.
通过细胞外囊泡将EMMPRIN流入循环是MT1-MMP依赖的.
在MFS TAA组织和血中研究EMMPRIN和MT1-MMP对于理解这些独特的特征至关重要.

研究的目的:

在MFS TAA组织和血中研究EMMPRIN和MT1-MMP之间的关系.
确定EMMPRIN在MFS大动脉纤维细胞中的分泌机制.
探索EMMPRIN和其他矩阵金属蛋白酶分析剂在MFSTAA中的诊断潜力.

主要方法:

从MFS TAA患者和健康对照中对大动脉组织和血中蛋白质标的量化.
操纵MT1-MMP丰富度和局部化在大动脉纤维细胞.
在条件培养介质中测量分泌的EMMPRIN.

主要成果:

与对照人群相比,EMMPRIN在MFS TAA组织中的水平升高,但在血中降低.
在MFSTAA组织中,MT1-MMP和TIMP-2的水平升高,而MMP-2和MMP-9的水平降低.
来自大动脉纤维细胞的EMMPRIN分泌取决于MT1-MMP内部化.

结论:

受MT1-MMP细胞局部化影响的EMMPRIN分泌受损,有助于MFS中组织EMMPRIN水平升高.
在MFSTAA中的明确的EMMPRIN水平,与其他MMP分析剂一起,将它们与对照区分开来.
这些发现表明EMMPRIN和MFSTAA中相关标记物的潜在诊断实用性.

关键词:

艾姆普林 (EMMPRIN) 是一种在 MT1-MMP 中,我们可以选择 MT1-MMP.马芬综合征是什么意思马芬综合征是什么意思胸前大动脉动脉瘤是什么?

更多相关视频

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Published on: March 8, 2019

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Published on: August 24, 2019

相关概念视频

Aortic Regurgitation I: Introduction

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Aneurysm I: Introduction

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...